Muhammad Saeed | Clinical Research | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Saeed | Clinical Research | Best Researcher Award

PRX Research | United States

Dr. Muhammad  Saeed is a highly accomplished physician and clinical research leader with extensive expertise in advancing medical innovation. He has dedicated his career to bridging clinical practice and research, focusing on infectious diseases, chronic illnesses, and novel therapeutics. With a foundation in medicine from Dow Medical College, he progressed to leadership positions in multiple U.S.-based clinical research centers, where he directed diverse clinical trials across infectious diseases, neurology, oncology, cardiology, and respiratory medicine. His contributions extend to both academia and industry, including collaborative work with prestigious global institutions. Dr. Saeed’s scholarly work encompasses book chapters and peer-reviewed publications that highlight his dedication to evidence-based medicine and medical education. Beyond his scientific contributions, he is recognized for mentoring young professionals and promoting ethical research practices. His blend of clinical acumen, research excellence, and leadership has positioned him as a key figure in modern translational research and therapeutic development.

Profile

ORCID

Education

Dr. Muhammad Saeed’s academic journey reflects a commitment to excellence and lifelong learning. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow Medical College, University of Karachi, laying the groundwork for his career in clinical medicine and research. His early training emphasized core competencies in surgery and internal medicine, which provided him with strong clinical insights that continue to inform his research leadership. He later pursued advanced studies at Johns Hopkins University, where he completed a Master of Science, equipping him with rigorous training in epidemiology, clinical trial design, and evidence-based research methodologies. His education also includes formative years at Habib Public School in Karachi, where he achieved GCE O’ Levels under the University of Cambridge Local Examination Syndicate. This broad educational foundation, spanning global institutions of repute, has allowed him to integrate strong clinical skills with research innovation, shaping his role as a physician-scientist and educator.

Experience

Dr. Muhammad Saeed’s professional experience spans diverse roles in clinical medicine and research. He began his medical career as a resident physician at Civil Hospital Karachi, training in surgery and medicine. His early exposure to hospital-based care was complemented by research responsibilities at Aga Khan University Hospital, where he worked as a Clinical Research Associate on infectious diseases and public health projects. Transitioning to the United States, he held leadership positions at Advanced Clinical Research Associates in Plano, HRMD Research in Dallas, and later Dallas Regional Medical Center and PRX Research in Mesquite, where he currently serves as Clinical Research Director. In these roles, he has overseen numerous multicenter, international clinical trials across therapeutic areas including oncology, neurology, cardiology, infectious diseases, and COVID-19. His leadership ensures regulatory compliance, patient safety, and high-quality outcomes in research. This experience highlights his ability to integrate patient care, research innovation, and administrative excellence.

Awards and Honors

Dr. Muhammad Saeed has been recognized for his outstanding contributions to clinical research, academic medicine, and patient-centered healthcare. His work in infectious disease research and clinical trial leadership has earned him respect among peers in both academic and industry settings. He has collaborated with leading researchers globally, resulting in publications and recognition in international medical circles. His co-authored book, What I Wish I Knew Before Medical School, reflects his dedication to mentoring and educating the next generation of healthcare professionals, further enhancing his academic reputation. His chapter contributions to the International Encyclopedia of Public Health positioned him among notable voices in global health. Over his career, he has been acknowledged for his role in advancing therapeutic development, particularly during the COVID-19 pandemic through multiple high-impact trials. These honors reflect not only his scholarly achievements but also his contributions to improving medical care through innovative and ethical clinical research practices

Research Focus

Dr. Muhammad Saeed’s research focus lies at the intersection of clinical innovation and public health. His academic research has addressed infectious diseases, including typhoid detection in children and diabetes risk factors in underserved communities. In industry, he has spearheaded large-scale multicenter clinical trials across diverse therapeutic areas, including cardiology, oncology, neurology, respiratory diseases, and COVID-19. His work emphasizes patient safety, treatment efficacy, and advancing therapeutic options for conditions with high unmet medical needs. He has been deeply involved in clinical trial design, implementation, and analysis, ensuring robust outcomes that translate into better clinical practices. Beyond therapeutic innovation, Dr. Saeed’s work reflects a commitment to advancing methodologies for early disease detection, novel biomarkers, stem-cell based therapies, and cutting-edge treatments for neurodegenerative and chronic illnesses. His research philosophy integrates medical rigor, ethical practice, and translational application, aiming to bring scientific discovery from the research bench directly to patient care with lasting global impact.

 

Publications

Title: Impacts of Ambient Temperatures on Pediatric Anemia in Sub-Saharan Africa: A Regional Ecological Study
Year: 2025

Title: Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis
Year: 2022

Title: Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19
Year: 2022

Title: Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Year: 2020

Title: Clinical characteristics, management and outcome of major pulmonary embolism: an experience from a tertiary care center in Pakistan
Year: 2009

Conclusion

Dr. Muhammad  Saeed is a distinguished physician-scientist whose career blends clinical expertise, research leadership, and academic scholarship, with a strong focus on advancing therapeutic innovation, improving patient care, and mentoring future medical professionals through global collaborations and ethical research excellence.

Gang Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Gang Liu | Medicine and Health Sciences| Best Researcher Award

The Affiliated Hospital of Guizhou Medical University | China

Gang Liu, M.D., is a highly regarded Professor and Chief Physician of Orthopaedics at the Department of Emergency Orthopedics, The Affiliated Hospital of Guizhou Medical University. Serving also as a Master’s Supervisor, Dr. Liu has made substantial contributions to orthopaedic trauma care, with a clinical and academic career rooted in improving outcomes for patients with complex fractures and injuries. Known for his precision in surgical techniques and commitment to academic mentoring, he leads innovative research in trauma surgery and biomechanics. His leadership in the department reflects his dedication to clinical excellence, education, and advancing orthopaedic science. As an influential voice in orthopaedic medicine in China, Dr. Liu combines decades of hands-on experience with a forward-looking approach to research and treatment, helping shape the next generation of specialists in trauma care. His work bridges the gap between clinical application and academic research, fostering advancements in evidence-based orthopaedic medicine.

Profile

ORCID

Education

While specific educational details about Dr. Gang Liu are not publicly listed, his current academic and professional status indicates extensive medical training, including the attainment of a Doctor of Medicine (M.D.) degree, likely followed by specialized residency and fellowship programs in orthopaedic surgery. As a Professor and Chief Physician, he has undoubtedly completed postgraduate and professional training in trauma and emergency orthopaedics, biomechanics, and surgical innovation. His role as a Master’s Supervisor suggests strong academic foundations and consistent engagement with scholarly research. Dr. Liu is affiliated with Guizhou Medical University, where he likely received or has contributed significantly to medical education. His educational trajectory exemplifies the rigorous academic and clinical preparation typical of senior physician-scientists in China’s leading medical institutions. His expertise reflects years of advanced learning in both clinical practice and orthopaedic science, enabling him to train the next generation of surgeons and researchers with a firm grounding in trauma and biomechanics.

Experience

Dr. Gang Liu currently serves at the Affiliated Hospital of Guizhou Medical University in Guiyang, China, where he is a Professor, Chief Physician in Orthopaedics, and a Master’s Supervisor. With decades of clinical and teaching experience, he plays a pivotal role in emergency orthopaedics, specializing in trauma management and fracture treatment. His leadership in the Department of Emergency Orthopedics involves not only patient care but also surgical innovation and departmental development. Dr. Liu has extensive experience in applying biomechanics to orthopaedic practice, aligning clinical strategies with research-based methodologies. His commitment to teaching and mentoring graduate students positions him as a key academic figure within the university. He integrates research, clinical service, and academic mentorship, demonstrating a rare balance of practical and theoretical knowledge in orthopaedics. His experience reflects the depth of his involvement in complex surgical procedures, clinical trials, and strategic planning for orthopaedic care in academic hospital settings.

Awards and Honors

Although detailed information on Dr. Gang Liu’s specific awards and honors is not publicly disclosed, his distinguished titles—Professor, Chief Physician, and Master’s Supervisor—indicate recognition for excellence in clinical practice, education, and research. Such positions in China’s medical hierarchy are awarded based on years of exceptional service, academic contributions, and leadership in healthcare delivery. It is likely that Dr. Liu has received institutional commendations and possibly regional or national recognition for his work in trauma and fracture care. His role in mentoring postgraduates suggests academic honors or commendations for teaching and research guidance. His contributions to biomechanics research and emergency orthopaedics may have earned him research grants or hospital-level awards for innovation or service excellence. As a senior figure at the Affiliated Hospital of Guizhou Medical University, he exemplifies the attributes of a respected physician-scientist whose reputation is built on both clinical outcomes and contributions to the academic and research mission of the institution.

Research Focus

Dr. Gang Liu’s research focuses on trauma, fracture management, and biomechanics in orthopaedic medicine. His work aims to improve understanding of the mechanical and biological responses of bone and soft tissue to injury, optimizing both surgical techniques and recovery outcomes. He explores how trauma impacts musculoskeletal function and how biomechanics can inform fracture fixation and healing strategies. At the Department of Emergency Orthopedics, Dr. Liu integrates research into clinical practice, conducting translational studies that advance evidence-based protocols in trauma care. His investigations likely include experimental and clinical trials, examining both traditional and modern surgical interventions. Emphasizing interdisciplinary collaboration, his research contributes to innovations in implant design, bone regeneration, and trauma surgery protocols. As a Master’s Supervisor, he mentors students on research methodologies, encouraging rigorous scientific exploration in orthopaedics. Dr. Liu’s research strengthens the link between clinical need and scientific discovery in the rapidly evolving field of emergency orthopaedic care.

Conclusion

Dr. Gang Liu stands as a dedicated leader in orthopaedic trauma care, combining clinical expertise, academic mentorship, and biomechanical research to improve patient outcomes and train future surgeons.

Muhammad Zia | Pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Zia | Pharmacology | Best Researcher Award

College of staten island | United States

Dr. Muhammad K. Zia is a medical professional and educator specializing in biological and medical sciences, currently serving as a Doctoral Lecturer in the Department of Biology at the College of Staten Island/CUNY. With an M.B.B.S. from Jinnah Sindh Medical University, Dr. Zia brings over two decades of diverse experience spanning clinical practice, higher education, and scientific research. He has contributed significantly to undergraduate science education through positions at Kean University, Fairleigh Dickinson University, and other academic institutions. His clinical background includes roles in pathology and diabetology in both the U.S. and Pakistan. Notably, he was awarded the PSC-CUNY research grant to study the effects of angiotensin receptor blockers on diabetic nephropathy. A dedicated mentor and presenter, Dr. Zia has supervised multiple student research posters and actively contributes to academic development at CSI. His interdisciplinary expertise uniquely bridges clinical knowledge with life science education and research.

Profile

ORCID

Education

Dr. Muhammad K. Zia earned his medical degree (M.B.B.S.) from Jinnah Sindh Medical University in Karachi, Pakistan. His training equipped him with a solid foundation in clinical medicine, including internal medicine, diagnostics, pathology, and patient care. Following graduation, he pursued additional clinical training and gained certification to practice medicine in Pakistan. Over time, he transitioned into academic medicine, combining his clinical expertise with pedagogy in biological sciences. He has complemented his education with ongoing professional development and has contributed to academic settings through student mentorship, course delivery, and research guidance. His deep understanding of clinical biology, pathology, and pharmacological interventions forms the basis of his teaching philosophy. While he holds no formal advanced academic degrees beyond his medical license, Dr. Zia has consistently demonstrated a commitment to educational excellence and medical scholarship, as evidenced by his active teaching roles and scholarly contributions in academic institutions in both the U.S. and abroad.

Experience

Dr. Zia’s professional journey reflects a balanced blend of academic instruction and clinical medicine. He has served as a Doctoral Lecturer at the College of Staten Island, following 12 years as an adjunct and substitute instructor. His teaching experience also spans Kean University, Union County College, Stevens Institute of Technology, and Wagner College, where he taught various biology and medical science courses. In the clinical domain, Dr. Zia has worked as a Medical Assistant in New Jersey, a Pathology Assistant at QDx Pathology Services, and held roles such as Associate Diabetologist and Resident Medical Officer at Baqai Medical University. Earlier in his career, he served as a Clinical Assistant at Imam Clinic in Karachi. His clinical responsibilities included diagnostics, treatment planning, minor procedures, and patient education. This extensive experience across multiple institutions showcases his ability to deliver science education enriched by real-world medical practice.

Awards and Honors

Dr. Muhammad K. Zia has been recognized for his commitment to academic research and mentorship through the PSC-CUNY Cycle 54 Research Grant. The award supported his study on the effects of Angiotensin Receptor Blockers in diabetic nephropathy, showcasing his initiative in clinical and retrospective research. His efforts to promote scientific inquiry among undergraduates were further highlighted through his supervision of multiple poster presentations at the CSI Undergraduate Conference on Research, Scholarship, and Arts. These included literature reviews on SGLT2 inhibitors, Parkinson’s disease interventions, and cardiovascular risks linked to supraventricular tachycardia. Dr. Zia has also presented workshops such as “How to Write a Reference Letter to Support Pre-Med Students,” contributing to the academic development of aspiring physicians. While he may not yet have amassed a wide array of traditional academic honors, his consistent involvement in student mentorship, curriculum enrichment, and funded research speaks volumes about his dedication and impact.

Research Focus

Dr. Zia’s research interests center on the intersection of clinical medicine and chronic disease management. His primary focus includes diabetic complications, particularly diabetic nephropathy and the therapeutic role of angiotensin receptor blockers. He is also interested in cardiovascular pharmacology and endocrinology, as demonstrated by his guidance of student research on SGLT2 inhibitors and their cardioprotective effects. His approach often involves retrospective chart reviews and critical literature analysis using credible medical databases like PubMed and the European Journal of Medicine. He further engages in collaborative educational research and academic mentoring, particularly within undergraduate settings. Dr. Zia’s supervised projects span diverse clinical areas, such as Parkinson’s disease interventions and arrhythmia outcomes, reflecting his broad scientific curiosity and integrative knowledge of pathophysiology. Through these initiatives, he fosters critical thinking and evidence-based research skills among students, contributing to a stronger foundation in translational medicine and interdisciplinary health sciences education.

Publications

Title: Comparative Evaluation of ARB Monotherapy and SGLT2/ACE Inhibitor Combination Therapy in the Renal Function of Diabetes Mellitus Patients: A Retrospective, Longitudinal Cohort Study
Year: 2025

Conclusion

Dr. Muhammad K. Zia’s multidimensional career—rooted in clinical medicine and expanded through academic instruction and student mentorship—demonstrates a sustained commitment to bridging medical science with impactful education and applied research.

Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications

Jesus Avila | Tauopathies | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Jesus Avila | Tauopathies | Best Researcher Award

Dr. Jesus Avila is a distinguished cognitive scientist and Professor ad honorem at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), Spain. He obtained his degree in Chemistry and PhD in Molecular Biology from Universidad Complutense Madrid, focusing on RNA polymerase in B. subtilis. His postdoctoral research at NIH, USA, centered on the SV40 virus. Throughout his prolific career, Dr. Avila has made groundbreaking contributions to understanding the neuronal cytoskeleton, particularly tau protein, its role in Alzheimer’s disease, and tauopathies. With over 694 published journal articles, 33 books, 4 patents, and collaborations across the USA, France, UK, Germany, and Spain, his work is internationally recognized. He serves on editorial boards of prestigious journals including EMBO J, FEBS Letters, Neuroscience, and Journal of Alzheimer’s Disease (Deputy Editor). Dr. Avila is a member of EMBO, Academia Europaea, AAAS, and Royal Academies of Sciences and Medicine of Spain.

Professional Profile

Education

Dr. Jesus Avila pursued his higher education at Universidad Complutense Madrid (UCM), earning a degree in Chemistry. He further specialized by completing a PhD in Molecular Biology at UCM, where his research focused on the B. subtilis RNA polymerase system. This solid foundation in molecular biology provided him with the expertise to investigate complex neurobiological mechanisms. He then advanced his academic career with postdoctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, USA, where he studied the SV40 virus—a crucial step that introduced him to advanced molecular virology and neurobiology techniques. This diverse academic background enabled him to establish a globally recognized research portfolio in neurodegeneration, particularly tau protein’s role in neuronal function and dysfunction.

Experience

Dr. Avila has an illustrious career spanning several decades at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), where he has led pioneering research into the neuronal cytoskeleton, tau protein dysfunction, and neurodegenerative diseases. His early research at NIH on SV40 virus provided him with robust molecular expertise, which he translated into comprehensive studies on tauopathies and Alzheimer’s disease upon returning to Spain. Dr. Avila has successfully led over 30 major research projects, consulted on 8 industry collaborations, and published 694 peer-reviewed articles. His work includes the authorship of 33 books and the filing of 4 patents. Through sustained collaborations with global leaders in neuroscience from the USA, France, UK, Germany, and Spain, he has significantly advanced the understanding of aging and cognitive decline. His academic leadership and editorial roles underscore his vast experience in guiding both research and scientific discourse.

Research Interests

Dr. Avila’s research primarily investigates the neuronal cytoskeleton, with a central focus on tau protein and its role in neurodegeneration. Beginning with tau’s structural function in neurons, his work has expanded to explore how tau dysfunction contributes to Alzheimer’s disease and other tauopathies. Utilizing molecular and cellular approaches, including advanced mouse models, he has dissected the pathological mechanisms linking tau pathology to cognitive decline. Recognizing aging as the principal risk factor for Alzheimer’s disease, his current investigations target neuronal rejuvenation strategies to mitigate age-associated neurodegeneration. His integrative approach combines molecular biology, neurogenetics, and translational models, contributing significantly to the understanding of disease progression and potential therapeutic interventions. Through over 694 publications, 33 books, multiple patents, and international collaborations, Dr. Avila has substantially advanced the field of cognitive neuroscience, particularly in understanding and combating tau-mediated cognitive disorders.

Awards

Dr. Avila’s exemplary contributions have earned him numerous prestigious honors. He is an elected member of EMBO (European Molecular Biology Organization), Academia Europaea, AAAS (American Association for the Advancement of Science), and both the Royal Academies of Sciences and Medicine of Spain—testament to his global recognition and scientific excellence. His editorial appointments with highly respected journals such as EMBO J, FEBS Letters, Neuroscience, and his role as Deputy Editor of the Journal of Alzheimer’s Disease further validate his authority in cognitive and neurodegenerative research. His citation index surpasses 100 on Scopus, reflecting the significant influence of his work. His extensive collaborations with leading international research teams highlight his status as a respected leader in the global scientific community. The combination of his research excellence, mentorship, and leadership has positioned him as one of the foremost experts in cognitive science and neurobiology.

Conclusion

Dr. Jesus Avila’s distinguished career combines pioneering research on tau protein and Alzheimer’s disease, extensive international collaborations, over 694 publications, leadership roles in major journals, multiple prestigious memberships, and an unwavering focus on neuronal rejuvenation strategies, positioning him as a world-leading cognitive scientist whose work continues to advance global understanding of neurodegeneration.

 Publications

  • Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer’s disease

    Experimental Neurology
    2025 | Journal article
    DOI: 10.1016/j.expneurol.2024.115049

    EID:

    2-s2.0-85208758184

    Part ofISSN: 10902430 00144886
    CONTRIBUTORS: Merino-Serrais, P.; Soria, J.M.; Arrabal, C.A.; Ortigado-López, A.; Esparza, M.Á.G.; Muñoz, A.; Hernández, F.; Ávila, J.; DeFelipe, J.; León-Espinosa, G.

  • Retrotransposon Protein L1 ORF1p Expression in Aging Central Nervous System

    International Journal of Molecular Sciences
    2025-05-04 | Journal article
    DOI: 10.3390/ijms26094368
    CONTRIBUTORS: Laura Vallés-Saiz; Aaron Abdelkader-Guillén; Jesús Ávila; Félix Hernández

  • Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

    Biochemistry
    2025-04-15 | Journal article
    DOI: 10.1021/acs.biochem.4c00809
    CONTRIBUTORS: Indalo Domene-Serrano; Raquel Cuadros; Vega García-Escudero; Francisco Vallejo-Bedia; Ismael Santa-María; Laura Vallés-Saiz; Félix Hernandez; Jesús Avila

  • Peptide Family Promotes Brain Cell Rejuvenation and Improved Cognition through Peripheral Delivery

    ACS Omega
    2025-04-08 | Journal article
    DOI: 10.1021/acsomega.4c10849
    CONTRIBUTORS: Alejandro Anton-Fernandez; Indalo Domene-Serrano; Raquel Cuadros; Rocio Peinado-Cahuchola; Margarita Sanchez-Pece; Felix Hernandez; Jesus Avila

  • Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer\’s disease

    Progress In Neurobiology
    2025-04-01 | Journal article | Author
    DOI: 10.1016/j.pneurobio.2025.102743

    SOURCE-WORK-ID:

    CSIC-GB950859

    EID:

    2-s2.0-85219079150

    Part ofISSN: 0301-0082
    CONTRIBUTORS: Alejandro Anton-Fernandez; Ruiz de Alegría, Álvaro; Mariscal-Casero, Ana; Roldán-Lázaro, Marta; Peinado-Cauchola, Rocío; Jesus Avila; Felix Hernandez

  • Hippocampal rejuvenation by a single intracerebral injection of one‐carbon metabolites in C57BL6 old wild‐type mice

    Aging Cell
    2025-01 | Journal article
    DOI: 10.1111/acel.14365
    CONTRIBUTORS: Alejandro Antón‐Fernández; Rocío Peinado Cauchola; Félix Hernández; Jesús Ávila

  • Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3

    eBioMedicine
    2024 | Journal article
    DOI: 10.1016/j.ebiom.2023.104953

    EID:

    2-s2.0-85181837483

    Part ofISSN: 23523964
    CONTRIBUTORS: Ruiz-Gabarre, D.; Vallés-Saiz, L.; Carnero-Espejo, A.; Ferrer, I.; Hernández, F.; Garcia-Escudero, R.; Ávila, J.; García-Escudero, V.

  • Involvement of the cellular prion protein in seeding and spreading of sarkosyl-derived fractions of Alzheimer´s disease in Prnp mutant mice and in the P301S transgenic tauopathy mice model

    bioRxiv
    2024 | Other
    DOI: 10.1101/2024.01.20.576414

    EID:

    2-s2.0-85184321414

    Part of ISSN: 26928205
    CONTRIBUTORS: Sala-Jarque, J.; Gil, V.; Andrés-Benito, P.; Lidón, L.; Yanac-Huertas, R.E.; López-León, C.F.; Hernández, F.; Ávila, J.; Lanciego, J.L.; Soriano, J. et al.

Nastaran Zamani | Exercise – Appetite – Obesity | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Nastaran Zamani | Exercise – Appetite – Obesity | Best Researcher Award

Dr. Nastaran Zamani is a distinguished Iranian neuroscientist and Assistant Professor in the Department of Biology at Payame Noor University, Tehran. With a research career grounded in neurophysiology and Alzheimer’s disease models, she has made valuable contributions to understanding the effects of neuroprotective agents like memantine, vitamin D, folic acid, and DHA on cognitive function. Her expertise spans from electrophysiological recordings of hippocampal neurons to behavioral studies in rodent models. Dr. Zamani has actively collaborated with renowned researchers and co-authored over 20 peer-reviewed articles published in leading journals in neuroscience, physiology, and pharmacology. Her work bridges cellular neurobiology and therapeutic research, reflecting an interdisciplinary approach. Dr. Zamani is also known for her participation in national and international scientific congresses. Through her teaching and mentoring roles, she fosters academic growth and promotes scientific inquiry among students and young researchers in Iran. Her commitment to neuroscience research and education continues to inspire many in the field.

Professional Profile

Googlescholar

Education

Dr. Nastaran Zamani earned her Ph.D. in Animal Physiology from Shahid Chamran University of Ahvaz in 2019, with a doctoral thesis focused on the electrophysiological and behavioral effects of memantine and DHA on hippocampal CA1 neurons and spatial memory in Alzheimer’s disease rat models, under the supervision of Prof. Ahmad Ali Moazedi. She completed her MSc in Animal Physiology from Razi University, Kermanshah, in 2004, where her thesis explored the hematological effects of sodium nitrate in mice, co-supervised by Dr. Syrus Shamili and Dr. Syrus Ghobadi. Her academic foundation was built at the University of Isfahan, where she received her BSc in Biology with a focus on Animal Sciences in 1999. Her education reflects a consistent and deep interest in the physiological and biochemical mechanisms underlying cognitive and neurodegenerative disorders, forming the basis of her current research in neuroscience and therapeutic interventions for Alzheimer’s disease and related neurological conditions.

Experience

Dr. Zamani began her academic career as a faculty instructor in the Department of Biology at Payame Noor University from 2011 to 2019. Since 2019, she has held the position of Assistant Professor in the same department. She has over a decade of teaching experience, mentoring undergraduate and graduate students in physiology, neurobiology, and experimental research techniques. Her research focuses on Alzheimer’s disease models, involving electrophysiology, behavioral neuroscience, and pharmacological interventions. Dr. Zamani has presented her findings in more than ten national and international conferences and has authored over 20 peer-reviewed journal articles in neuroscience and physiology. In addition to teaching and research, she has participated in various academic development workshops on molecular biology, drug delivery, data analysis using MATLAB, and scientific writing. Her continuous contributions to neuroscience research and education have strengthened her role as a dedicated academic professional in the Iranian scientific community.

Research Interests

Dr. Zamani’s research centers on the neurophysiological and therapeutic mechanisms underlying Alzheimer’s disease, with a primary focus on hippocampal CA1 neuron activity, memory, and learning. She explores the pharmacological effects of memantine, folic acid, vitamin B12, DHA, and vitamin D in rodent models of neurodegeneration, using electrophysiological recordings and behavioral assessments such as maze tests. Her investigations examine how these compounds influence spatial learning, memory deficits, neuroinflammation, and oxidative stress in Alzheimer’s models. She has expanded her research to include studies on motor coordination, depression, anxiety, and thermal dysregulation related to neurological disorders, as well as broader physiological effects of exercise and natural antioxidants. Her interdisciplinary approach integrates neuroscience, pharmacology, and physiology, supported by collaborations with international researchers and active engagement in congresses and workshops. By bridging cellular mechanisms and therapeutic strategies, Dr. Zamani’s work contributes significantly to preclinical efforts targeting Alzheimer’s disease and cognitive disorders.

Awards

While formal award titles are not explicitly listed, Dr. Nastaran Zamani’s consistent scholarly productivity and academic recognition are evident through her extensive peer-reviewed publications, conference participations, and workshop invitations. She has been selected to present at prestigious neuroscience congresses, such as the Congress of Basic and Clinical Neuroscience, and has contributed to multiple multidisciplinary international collaborations, demonstrating her recognition within the academic community. Her research contributions to Alzheimer’s disease models have earned her collaborative roles in high-impact studies published in journals like Frontiers in Physiology, Molecular and Cellular Biochemistry, and Cytotherapy. She has also participated in professional development programs hosted by Tehran University of Medical Sciences, Elsevier Research Academy, and the International Brain Research Organization, further reflecting her ongoing commitment to academic excellence. Dr. Zamani’s profile highlights the high regard she holds among peers and institutions for her active role in advancing neurophysiological research in Iran and beyond.

Conclusion:

Dr. Nastaran Zamani is a dedicated neuroscientist whose innovative research on neurodegeneration and therapeutic interventions for Alzheimer’s disease has significantly advanced our understanding of cognitive function, making her a valuable contributor to the global neuroscience community.

 

Top Noted Publications

Paula San Martín González | Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Paula San Martín González | Health Sciences | Best Researcher Award

Paula San Martín González, born in Salamanca, Spain, is a dedicated academic and healthcare professional currently serving as Profesora Ayudante Doctora at Universidad Pontificia de Salamanca. With a solid foundation in nursing, she has steadily advanced through both clinical and academic pathways. She holds a PhD in Human and Social Sciences and multiple master’s degrees in oncology, critical care, and emergency nursing, as well as in teaching secondary education. She has also earned postgraduate expertise in leadership, management, and ultrasound in nursing care. Since 2017, she has been deeply involved in higher education, delivering over 20 courses in nursing and health sciences. Recognized with the DOCENTIA award, her contributions span simulation-based teaching, innovation in health education, and interdisciplinary learning. Paula continues to enrich healthcare pedagogy through teaching, research, and curriculum development in simulation-based clinical practice.

Profile

🎓 Education

Paula San Martín González completed her Bachelor’s in Nursing at Universidad Pontificia de Salamanca in 2014. She pursued specialized education with three official master’s degrees: one in Palliative Care for Oncology Patients (University of Salamanca, 2016), another in Critical and Emergency Nursing (University of León, 2017), and a third in Secondary and Vocational Education Teaching (UPSA). Additionally, she earned postgraduate qualifications in Leadership in Nursing Services (UDIMA, 2020) and Clinical Ultrasound for Nursing (Universidad Católica de Ávila, 2024). Her academic journey culminated in a PhD in Human and Social Sciences from Universidad Pontificia de Salamanca in 2022. Notably, she also became an Instructor in Advanced Clinical Simulation (UCAM, 2020), further deepening her pedagogical capabilities. Her educational background reflects a harmonious blend of clinical, academic, and teaching excellence, equipping her to bridge the gap between theoretical learning and healthcare practice with precision and empathy.

🧪 Experience

Paula has accumulated diverse experience in clinical and academic settings. She began her career as a nurse at Fundación Hospital General de la Santísima Trinidad (2015–2016) and later worked at Hospital Universitario Marqués de Valdecilla (2016–2017). In 2017, she transitioned to academia, joining Universidad Pontificia de Salamanca as a full-time Profesora Ayudante, later promoted to Profesora Ayudante Doctora in 2024. Her teaching portfolio spans over 25 university-level nursing and education courses, including mental health nursing, health alterations, community nursing, clinical practicums, and simulation-based learning. She also taught in collaborative programs like the University of Experience and courses at the University of Burgos. Alongside teaching, she has delivered workshops and seminars on simulation, leadership, and innovation in nursing education. Her consistent progression from bedside care to academic excellence highlights a commitment to training future nursing professionals through innovation, clinical insight, and dedication.

🏅 Awards and Honors

Paula San Martín González has been recognized for her exceptional teaching contributions with the DOCENTIA Award granted by Universidad Pontificia de Salamanca in 2024. This prestigious award acknowledges excellence in university teaching and reflects her high-quality performance in classroom instruction and academic mentorship. Her teaching activity from 2017 to 2021 was evaluated as Excellent by the ACSUCYL/ANECA accreditation bodies, affirming her effectiveness and impact as an educator. Additionally, she earned positive accreditation for the rank of Profesor Ayudante Doctor in 2024, further validating her professional competence and qualifications within Spain’s higher education system. Her commitment to innovative teaching methodologies, such as clinical simulation and patient-standardized training, has also contributed to her recognition as a leader in educational innovation. These accolades underscore her influence in the academic community and her drive to elevate the standards of nursing education.

🔬 Research Focus

Paula’s research centers on clinical simulation, educational innovation in nursing, leadership development, and digital health literacy. She is especially invested in exploring how simulation methodologies improve the practical training of nursing students. Her published work includes book chapters on simulation-based instruction using standardized patients, the integration of social media in health education, and strategies to foster entrepreneurial leadership among health sciences students. These contributions reflect her broader goal to blend academic rigor with technological advancements in pedagogy. She is a leading author in projects linked to educational transformation, particularly through simulation and interdisciplinary collaboration. Moreover, her research supports reflective, student-centered learning models that promote critical thinking, self-efficacy, and adaptive clinical decision-making. Her engagement with simulation-based projects aligns with current trends in nursing education and contributes to a deeper, evidence-based understanding of its efficacy in real-world preparedness for healthcare professionals.

✅ Conclusion

Paula San Martín González exemplifies a modern nursing educator whose blend of clinical expertise, academic excellence, and pedagogical innovation—particularly through simulation-based learning—positions her as a transformative force in healthcare education.

Publications

  • Promotion of Healthy Habits in Adolescents: An Interdisciplinary Study on Motivation Towards Physical Education, Mediterranean Diet and Physical Activity

    Behavioral Sciences
    2025-06 | Journal article | Author
    DOI: 10.3390/bs15060778
    CONTRIBUTORS: Paula San Martín González; José Enrique Moral García; Mario Amatria Jiménez; Rubén Arroyo Del Bosque

  • Prevalence of burnout syndrome among veterinarians in SpainJournal of the American Veterinary Medical Association

    2023-02-07 | Journal article
    DOI: 10.2460/javma.22.09.0407
    Part ofISSN: 0003-1488
    CONTRIBUTORS: Álvaro San Martín González; Paula San Martín González; María-Prado Míguez-Santiyán; Francisco Soler Rodríguez; Marcos Pérez-López

  • Manejo del dolor en el paciente terminal oncológico

    Cuidados en salud en iberoamérica
    2022 | Journal article
    CONTRIBUTORS: Paula San Martín González

Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Assos. Prof. Dr. Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Dr. Konrad Talbot is a distinguished neuroscientist and Associate Professor at Loma Linda University School of Medicine, serving in the Departments of Neurosurgery, Pathology & Human Anatomy, and Basic Sciences since 2018. He specializes in investigating the pathogenesis and treatment of neurodegenerative and psychiatric disorders, particularly focusing on brain insulin resistance in Alzheimer’s and Parkinson’s diseases. With a Ph.D. in Physiological Psychology from UCLA and extensive postdoctoral training at the University of Pennsylvania, Dr. Talbot has held faculty and research positions at leading institutions such as Cedars-Sinai, UCLA, and UPenn. He is a highly cited researcher (H-index: 34, 9341 citations), with significant NIH and international grant support. He also serves as an editorial board member, reviewer, and invited speaker at global conferences. His work has influenced both fundamental neuroscience and the development of therapeutic strategies for brain diseases.

Profile

🎓 Education

Dr. Konrad Talbot completed his undergraduate (B.A.), master’s (M.A.), and doctoral (Ph.D.) degrees in Psychology with a specialization in Physiological Psychology at the University of California, Los Angeles (UCLA). His academic path reflects a deep commitment to understanding the biological underpinnings of behavior and brain function. He also received formal teaching certification from UCLA’s Instructor Development Program in 1992. His postdoctoral training included pivotal roles at the University of Pennsylvania’s Department of Pathology and Laboratory Medicine and the Center for Neurodegenerative Disease Research (1997–2001), where he developed expertise in brain autopsy and pathology. He furthered his technical capabilities through advanced training in quantitative fluorescence microscopy at Mount Desert Island Biological Laboratory in 2007. His broad educational background forms a strong foundation for his interdisciplinary research and teaching roles across psychology, neurobiology, pathology, and medical sciences.

🧪 Experience

Dr. Talbot’s academic journey spans over three decades, beginning as an Assistant Professor at Mount St. Mary’s College and St. Olaf College, where he taught psychology and mentored numerous students. He transitioned into intensive research roles at the University of Pennsylvania (UPenn) from 1997 to 2012, ascending from postdoctoral investigator to senior research investigator and research faculty. He later held associate research professorships at Cedars-Sinai Medical Center and UCLA. Since 2018, he has served as Associate Professor at Loma Linda University. Dr. Talbot has authored influential studies on brain insulin resistance, taught neuroanatomy to medical residents, supervised postdoctoral and undergraduate research projects, and served in various academic leadership and committee roles. In addition to his research and teaching, he has contributed editorial expertise to high-impact journals and consulted on landmark neuroanatomical atlases. His career reflects a blend of teaching excellence, pioneering research, and interdisciplinary leadership.

🏅 Awards and Honors

Dr. Talbot’s contributions have been widely recognized through prestigious awards and honors. In 2003, he received the T.L.L. Temple Foundation Discovery Award from the Alzheimer’s Association for his groundbreaking work on brain insulin resistance. He was honored as a co-dedicatee of the influential neuroscience text The Mouse Brain in Stereotaxic Coordinates (2008 edition), highlighting his impact on anatomical brain mapping. In 2020, he was inducted into the Sigma Chi Scientific Research Honor Society. His professional affiliations include long-standing memberships with the Society for Neuroscience, Alzheimer Research Forum, Schizophrenia Research Forum, and ISTAART (International Society to Advance Alzheimer Research and Treatment). He has played leadership roles in organizing major scientific conferences, chaired institutional committees, and served on advisory panels. His editorial contributions and invited lectures worldwide further underscore the scientific community’s high regard for his research excellence and thought leadership.

🔬 Research Focus

Dr. Talbot’s research centers on identifying and targeting mechanisms underlying neurodegenerative and psychiatric diseases, with a special emphasis on insulin resistance in the brain. He has pioneered investigations showing that brain insulin resistance plays a critical role in Alzheimer’s and Parkinson’s disease pathogenesis. His NIH-funded work explores the therapeutic potential of incretin receptor agonists—an emerging class of antidiabetics—in reducing brain insulin resistance and improving cognitive function. His collaborative projects with institutions like CUNY, UCLA, and the University of Washington focus on both human brain tissue analysis and preclinical models. Past research includes the molecular biology of schizophrenia, especially dysbindin-related pathways. He holds a U.S. patent application on methods for treating brain insulin resistance, signaling the translational potential of his findings. Dr. Talbot’s research integrates neuropharmacology, pathology, neuroanatomy, and clinical neuroscience, aiming to develop disease-modifying treatments that can halt or reverse progression in cognitive and psychiatric disorders.

✅ Conclusion

Dr. Konrad Talbot is an accomplished neuroscientist whose multidisciplinary work in brain insulin resistance has significantly advanced understanding and treatment approaches for Alzheimer’s and Parkinson’s diseases, blending rigorous research, impactful teaching, and translational innovation.

Publications

Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award


Dr. Ejaz Ahmad Khera is an Assistant Professor of Physics at The Islamia University of Bahawalpur, Pakistan, and an HEC-approved supervisor with a PhD in the characterization of materials for memory storage and neuromorphic applications using DFT. He has published over 30 high-impact international research articles and currently leads research at the Materials Modeling and Simulation Lab, where he supervises MPhil and PhD students. His group is actively involved in developing efficient double perovskites for solar cell applications. In addition to his academic and research roles, Dr. Khera contributes to departmental administrative functions and has participated in multiple international conferences in physics and materials science. He is proficient in VASP, Wien2k, CASTEP, and other computational tools, reflecting his strong background in computational materials physics.

Profile

Education 🎓

Dr. Khera earned his PhD in Physics from The Islamia University of Bahawalpur (2016–2021), focusing on DFT-based characterization of materials for neuromorphic and memory applications. He holds an MPhil in Physics from Allama Iqbal Open University, Islamabad (2012–2014), and a Master of Science in Physics from Bahauddin Zakariya University, Multan (2007–2010). His academic foundation combines theoretical physics, computational modeling, and practical understanding of solid-state and condensed matter systems. He is trained in multiple simulation platforms including VASP, Wein2k, and CASTEP, and has built expertise in data analysis software like Origin and visualization tools like VESTA and Crystal Maker. His solid academic training has enabled him to mentor graduate students in computational material science and renewable energy research domains. Dr. Khera has also enhanced his academic exposure through participation in pedagogical and research methodology training programs.

Experience 👨‍🏫

Dr. Khera is currently serving as Assistant Professor of Physics at The Islamia University of Bahawalpur since March 2022, where he teaches undergraduate and postgraduate courses, leads research, and manages academic administration. From 2019 to 2021, he was a visiting lecturer at University of Education, Multan Campus, and previously taught physics at Admire Group of Colleges (2017–2021), Muslim Group of Colleges (2013–2017), and Educators Group of Colleges (2011–2013), focusing on undergraduate and higher secondary education. Over a decade of teaching experience has honed his expertise in delivering core physics concepts and mentoring students. In his academic tenure, Dr. Khera has also built research collaborations and guided MPhil and PhD students in materials modeling. His responsibilities have included curriculum design, academic planning, and seminar coordination. He is deeply engaged in academic development through active participation in physics conferences and workshops.

Awards & Recognitions 🏅

Dr. Khera received the Prime Minister Youth Laptop Scheme award from the Federal Government of Pakistan in 2018, recognizing his academic excellence and contribution to higher education. He was also granted the Punjab Government Scholarship under the Fee Reimbursement Scheme for Higher Education in 2017, awarded by the Government of Punjab. These honors reflect his academic merit, commitment to research, and service in the field of physics education. He has participated in multiple international and national-level conferences, including events hosted by The Islamia University of Bahawalpur and The Women University Multan. His consistent performance in academics and his role in teaching and research supervision have earned him institutional recognition. Additionally, his HEC-approved supervisor status further signifies his qualification and leadership in guiding advanced research projects in Pakistan. These accolades support his active involvement in national education development and scientific advancement in materials science.

Research Interests 🔬

Dr. Khera’s research is centered on computational materials science with a focus on density functional theory (DFT)-based investigations of electronic, optical, thermoelectric, and structural properties of novel materials. His primary interest lies in characterizing double perovskites (DPs), Heusler alloys, and vacancy-ordered compounds for use in solar cells, memory storage, brain-inspired neuromorphic systems, and energy harvesting applications. Using simulation tools like VASP, CASTEP, and Wien2k, he studies materials such as Ga₂PtX₆, Li₂ATlCl₆, and Na₂PtX₆ for their optoelectronic and thermoelectric performance. His recent publications explore halogen modification, spin polarization, and hybrid perovskites for sustainable technologies. His research group actively contributes to discovering lead-free, high-efficiency materials that align with global goals for clean and renewable energy. Dr. Khera also collaborates internationally, co-authoring papers with scientists across Asia and Europe, thereby advancing the field of computational physics and sustainable material development.

Publications

 

  • Probing the opto-electronic, thermoelectric, thermodynamic and elastic responses
    of lead-free double perovskite Li2ATlCl6 (A= Na and K) for potential photovoltaic
    and high-energy applications: A DFT study
    Reference: Qiguo Xiao, Abrar Nazir, Ejaz Ahmad Khera, Mumtaz Manzoor, Ramesh
    Sharma, Javed Rahman, Sabah Ansar, Farooq Ali
    Link: https://www.sciencedirect.com/science/article/pii/S0921510724006895

 

  • First principles investigation of structural, electronic, optical, transport properties
    of double perovskites X2TaTbO6 (X= Ca, Sr, Ba) for optoelectronic and energy
    harvesting applications
    Reference: Mudassir Ishfaq, Muniba Urooj, Muhammad Sajid, Khawar Ismail, Rimsha
    Baqeel, Ejaz Ahmad Khera, Rajwali Khan, Sattam Al Otaibi, Khaled Althubeiti, Hassan Ali,
    Ghulam Murtaza, Muhammad Jamil
    Link: https://www.sciencedirect.com/science/article/pii/S0022369724005675